ERBB2 and breast cancer: However, different intrinsic subtypes are mixed in HER2-positive breast cancer, that is, 51% showed HER2-enriched type, 28% showed luminal type, and 21% showed the typical intrinsic subtypes for triple negative breast cancer such as basal type, claudin-low type, and normal-like type [17].